KMHH-03 | m-entrepreneurship.com

Product Name :
KMHH-03

Search keywords :
uPAR

drugId :
null

Target Vo:
Heat Shock Protein 90 Beta Family Member 1

Target Vo Short Name :
HSP90B1

Moa_Name:
Heat Shock Protein 90 Beta Family Member 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Beijing Kangming Haihui Biological Technology Co Ltd

Active Company_Name :

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sotatercept custom synthesis
Aducanumab site
DLST Antibody: DLST Antibody is an unconjugated, approximately 41 kDa, rabbit-derived, anti-DLST polyclonal antibody. DLST Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF, expriments in mouse and predicted: human, rat, dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts